BANK OF AMERICA CORP /DE/ - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 31 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$0160
-27.3%
0.00%
Q3 2018$0220
+1900.0%
0.00%
Q2 2018$0
-100.0%
11
-99.0%
0.00%
Q1 2018$3,0001,102
+1047.9%
0.00%
Q4 2017$0
-100.0%
96
-98.8%
0.00%
Q2 2017$33,000
+6.5%
8,284
-0.9%
0.00%
Q1 2017$31,000
+93.8%
8,3630.0%0.00%
Q4 2016$16,0008,3630.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2017
NameSharesValueWeighting ↓
Aisling Capital LLC 210,000$777,0000.14%
SEARLE & CO. 17,250$64,0000.04%
Jefferies Group LLC 259,200$959,0000.01%
Renaissance Technologies 740,650$2,740,0000.00%
Virtu KCG Holdings LLC 28,739$106,0000.00%
GROUP ONE TRADING, L.P. 19,945$74,0000.00%
SIMPLEX TRADING, LLC 4,950$18,0000.00%
IFP Advisors, Inc 427$2,0000.00%
Advisor Group, Inc. 177$1,0000.00%
BANK OF AMERICA CORP /DE/ 8,363$31,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders